OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
Miklós Bege, Anikó Borbás
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 909-909
Open Access | Times Cited: 27
Miklós Bege, Anikó Borbás
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 909-909
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: Mechanistic challenges, delivery strategies, and therapeutic applications
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124582-124582
Open Access | Times Cited: 34
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124582-124582
Open Access | Times Cited: 34
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 15
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 15
Natural, modified and conjugated carbohydrates in nucleic acids
Debashis Dhara, Laurence A. Mulard, Marcel Hollenstein
Chemical Society Reviews (2025)
Open Access | Times Cited: 1
Debashis Dhara, Laurence A. Mulard, Marcel Hollenstein
Chemical Society Reviews (2025)
Open Access | Times Cited: 1
Recent Advances in Bioconjugated Transition Metal Complexes for Cancer Therapy
Enrica Bortolamiol, Fabiano Visentin, Thomas Scattolin
Applied Sciences (2023) Vol. 13, Iss. 9, pp. 5561-5561
Open Access | Times Cited: 22
Enrica Bortolamiol, Fabiano Visentin, Thomas Scattolin
Applied Sciences (2023) Vol. 13, Iss. 9, pp. 5561-5561
Open Access | Times Cited: 22
The current perspective and opportunities of small nucleic acid‐based therapeutics
Yang Chen, Yang Li, Chao Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 6
Yang Chen, Yang Li, Chao Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 6
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 6
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 6
Specificity of oligonucleotide gene therapy (OGT) agents
Daria D. Nedorezova, Mikhail V. Dubovichenko, Ekaterina P. Belyaeva, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 7132-7157
Open Access | Times Cited: 27
Daria D. Nedorezova, Mikhail V. Dubovichenko, Ekaterina P. Belyaeva, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 7132-7157
Open Access | Times Cited: 27
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
Lisa Agnello, Annachiara d’Argenio, Roberto Nilo, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2010-2010
Open Access | Times Cited: 14
Lisa Agnello, Annachiara d’Argenio, Roberto Nilo, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2010-2010
Open Access | Times Cited: 14
Synthesis and Resolution of 4′-Substituted Nucleosides with Potential Antiviral and Antisense Strategies
Yukino Endo, Keiji Itoh, Hiroya Kan‐no, et al.
The Journal of Organic Chemistry (2025)
Closed Access
Yukino Endo, Keiji Itoh, Hiroya Kan‐no, et al.
The Journal of Organic Chemistry (2025)
Closed Access
The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy
Miklós Bege, Rasha Ghanem Kattoub, Anikó Borbás
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 394-394
Open Access
Miklós Bege, Rasha Ghanem Kattoub, Anikó Borbás
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 394-394
Open Access
Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform
Suzanne Saffie-Siebert, Nissim Torabi-Pour, Andrew Gibson, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101299-101299
Open Access | Times Cited: 3
Suzanne Saffie-Siebert, Nissim Torabi-Pour, Andrew Gibson, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101299-101299
Open Access | Times Cited: 3
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges
Wanjun Yuan, Xiangyang Shi, Leo Tsz On Lee
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102195-102195
Open Access | Times Cited: 2
Wanjun Yuan, Xiangyang Shi, Leo Tsz On Lee
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102195-102195
Open Access | Times Cited: 2
An enantioselective and modular platform for C4ʹ-modified nucleoside analogue synthesis enabled by intramolecular trans-acetalizations
Nuligonda Thirupathi, Gautam Kumar, Jason W. Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Nuligonda Thirupathi, Gautam Kumar, Jason W. Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Bacterial thermophilic DNA polymerases: A focus on prominent biotechnological applications
Fatima Akram, Fatima Iftikhar Shah, Ramesha Ibrar, et al.
Analytical Biochemistry (2023) Vol. 671, pp. 115150-115150
Closed Access | Times Cited: 6
Fatima Akram, Fatima Iftikhar Shah, Ramesha Ibrar, et al.
Analytical Biochemistry (2023) Vol. 671, pp. 115150-115150
Closed Access | Times Cited: 6
Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen
Shunji Imai, Y Suda, Jumpei Mori, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1428-1435
Open Access | Times Cited: 5
Shunji Imai, Y Suda, Jumpei Mori, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 10, pp. 1428-1435
Open Access | Times Cited: 5
Why and How to Control P-Chirality in Phosphorothioated Therapeutic Oligonucleotides: Analytical Challenges Associated with Determination of Stereochemical Composition
Tanja Poredoš, Marko Trampuž, Tjaša Gornik, et al.
Organic Process Research & Development (2024)
Closed Access | Times Cited: 1
Tanja Poredoš, Marko Trampuž, Tjaša Gornik, et al.
Organic Process Research & Development (2024)
Closed Access | Times Cited: 1
Isomer analysis by mass spectrometry in clinical science
Takeshi Furuhashi, Wolfram Weckwerth
TrAC Trends in Analytical Chemistry (2022) Vol. 159, pp. 116907-116907
Closed Access | Times Cited: 7
Takeshi Furuhashi, Wolfram Weckwerth
TrAC Trends in Analytical Chemistry (2022) Vol. 159, pp. 116907-116907
Closed Access | Times Cited: 7
N‐Fluoroalkylated Morpholinos – a New Class of Nucleoside Analogues
Nóra Debreczeni, Judit Hotzi, Miklós Bege, et al.
Chemistry - A European Journal (2022) Vol. 29, Iss. 11
Open Access | Times Cited: 6
Nóra Debreczeni, Judit Hotzi, Miklós Bege, et al.
Chemistry - A European Journal (2022) Vol. 29, Iss. 11
Open Access | Times Cited: 6
Deciphering HERG mutation in long QT syndrome type 2 using antisense oligonucleotide–mediated techniques: Lessons from cystic fibrosis
Zequn Zheng, Yongfei Song, Xuerui Tan
Heart Rhythm (2023) Vol. 20, Iss. 8, pp. 1169-1177
Closed Access | Times Cited: 2
Zequn Zheng, Yongfei Song, Xuerui Tan
Heart Rhythm (2023) Vol. 20, Iss. 8, pp. 1169-1177
Closed Access | Times Cited: 2
Adjuvant Oligonucleotide Vaccine Increases Survival and Improves Lung Tissue Condition of B6.Cg-Tg (K18-ACE2)2 Transgenic Mice
Volodymyr V. Oberemok, Kateryna V. Laikova, Kseniya A. Yurchenko, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 3, pp. 35-35
Open Access | Times Cited: 2
Volodymyr V. Oberemok, Kateryna V. Laikova, Kseniya A. Yurchenko, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 3, pp. 35-35
Open Access | Times Cited: 2
Structural and Dynamic Features of the Recognition of 8-oxoguanosine Paired with an 8-oxoG-clamp by Human 8-oxoguanine-DNA Glycosylase
Maria V. Lukina, Polina V. Zhdanova, Vladimir V. Koval
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4119-4132
Open Access
Maria V. Lukina, Polina V. Zhdanova, Vladimir V. Koval
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4119-4132
Open Access
FORMATION AND STUDY OF MULTICOMPONENT SYSTEMS CONTAINING BIOLOGICALLY ACTIVE AGENTS BY SPECTRAL AND HYDRODYNAMIC METHODS
Nina A. Kasyanenko, Vasiliy А. Bakulev, Daria Artamonova
Russian Journal of Biological Physics and Chemisrty (2024) Vol. 8, Iss. 3, pp. 237-241
Open Access
Nina A. Kasyanenko, Vasiliy А. Bakulev, Daria Artamonova
Russian Journal of Biological Physics and Chemisrty (2024) Vol. 8, Iss. 3, pp. 237-241
Open Access
Marker‐dependent cleavage of RNA by binary (split) DNAzyme (BiDz) and binary DNA machines (biDNM)
Mikhail V. Dubovichenko, Daria D. Nedorezova, Christina Patra, et al.
ChemBioChem (2024)
Open Access
Mikhail V. Dubovichenko, Daria D. Nedorezova, Christina Patra, et al.
ChemBioChem (2024)
Open Access
siRNA: A Comprehensive Review of Marketed Products till August 2022
Rupali Ghosh, Md. Iqbal Hossain Nayan, Tirtha Nandi
Journal of Advances in Medical and Pharmaceutical Sciences (2023) Vol. 25, Iss. 1, pp. 31-43
Open Access | Times Cited: 1
Rupali Ghosh, Md. Iqbal Hossain Nayan, Tirtha Nandi
Journal of Advances in Medical and Pharmaceutical Sciences (2023) Vol. 25, Iss. 1, pp. 31-43
Open Access | Times Cited: 1
Amides and Other Nonionic Backbone Modifications in RNA
Eriks Rozners
(2023), pp. 1-21
Closed Access | Times Cited: 1
Eriks Rozners
(2023), pp. 1-21
Closed Access | Times Cited: 1
